Control of myeloid cell trafficking in resolution

Journal of Innate Immunity

Volumn 5, Issue 4, 2013, Pages 367-376

  Norling, Lucy V ^a   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Annexin A1; Apoptosis; Efferocytosis; G protein coupled receptor; Resolvin

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIPOCORTIN 1; FORMYLMETHIONYLLEUCYLPHENYLALANINE; G PROTEIN COUPLED RECEPTOR KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

BONE MARROW CELL; CELL MIGRATION; FIBROSIS; HOMEOSTASIS; HUMAN; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MEDIATOR; MONOCYTE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; CELLS BY BODY ANATOMY; DENDRITIC CELL; EXPERIMENTAL PERITONITIS; IMMUNE RESPONSE; LYMPH NODE; LYMPH VESSEL; MEDIATOR RELEASE; NEUTROPHIL CHEMOTAXIS; PHAGOCYTOSIS;

ANIMALS; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELL MOVEMENT; HOMEOSTASIS; HUMANS; INFLAMMATION; MONOCYTES; MYELOID CELLS; PHAGOCYTOSIS; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION;

EID: 84876799272     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000350612     Document Type: Review

References (91)

1. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, Wallace JL: Resolution of inflammation: State of the art, definitions and terms. FASEB J 2007; 21: 325-332 (Pubitemid 46213480)
2. Serhan CN: Lipoxins and aspirin-Triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 141-162 (Pubitemid 41253472)
3. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN: Lipid mediator class switching during acute inflammation: Signals in resolution. Nat Immunol 2001; 2: 612-619 (Pubitemid 32677628)
4. Serhan CN: Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007; 25: 101-137 (Pubitemid 46697904)
5. Perretti M, D'Acquisto F: Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 2009; 9: 62-70
6. Damazo AS, Yona S, Flower RJ, Perretti M, Oliani SM: Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J Immunol 2006; 176: 4410-4418 (Pubitemid 44264421)
7. Maderna P, Yona S, Perretti M, Godson C: Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-Treated macrophages and annexin-derived peptide Ac(2-26). J Immunol 2005; 174: 3727-3733 (Pubitemid 40354084)
8. Leoni G, Patel HB, Sampaio AL, Gavins FN, Murray JF, Grieco P, Getting SJ, Perretti M: IUnflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptornull mice after ischemia-reperfusion. FASEB J 2008; 22: 4228-4238
9. Montero-Melendez T, Patel HB, Seed M, Nielsen S, Jonassen TE, Perretti M: The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties. Am J Pathol 2011; 179: 259-269
10. Catania A, Lonati C, Sordi A, Carlin A, Leonardi P, Gatti S: The melanocortin system in control of inflammation. Sci World J 2010; 10: 1840-1853
11. Lam CW, Getting SJ, Perretti M: IUn vitro and in vivo induction of heme oxygenase 1 in mouse macrophages following melanocortin receptor activation. J Immunol 2005; 174: 2297-2304 (Pubitemid 40223978)
12. Soehnlein O, Lindbom L: Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010; 10: 427-439
13. Geissmann F, Jung S, Littman DR: Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82 (Pubitemid 36859902)
14. Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964 (Pubitemid 41746764)
15. Lominadze G, Powell DW, Luerman GC, Link AJ, Ward RA, McLeish KR: Proteomic analysis of human neutrophil granules. Mol Cell Proteomics 2005; 4: 1503-1521 (Pubitemid 41555476)
16. Soehnlein O, Zernecke A, Eriksson EE, Rothfuchs AG, Pham CT, Herwald H, Bidzhekov K, Rottenberg ME, Weber C, Lindbom L: Neutrophil secretion products pave the way for inflammatory monocytes. Blood 2008; 112: 1461-1471
17. Maddox JF, Serhan CN: Lipoxin A 4 and B 4 are potent stimuli for human monocyte migration and adhesion: Selective inactivation by dehydrogenation and reduction. J Exp Med 1996; 183: 137-146
18. Blume KE, Soeroes S, Keppeler H, Stevanovic S, Kretschmer D, Rautenberg M, Wesselborg S, Lauber K: Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic 'find-me' signal. J Immunol 2012; 188: 135-145
19. Vong L, D'Acquisto F, Pederzoli-Ribeil M, Lavagno L, Flower RJ, Witko-Sarsat V, Perretti M: Annexin 1 cleavage in activated neutrophils: A pivotal role for proteinase 3. J Biol Chem 2007; 282: 29998-30004 (Pubitemid 350035249)
20. Dalli J, Montero-Melendez T, McArthur S, Perretti M: Annexin A1 N-Terminal derived peptide Ac2-26 exerts chemokinetic effects on human neutrophils. Front Pharmacol 2012; 3: 28
21. Vago JP, Nogueira CR, Tavares LP, Soriani FM, Lopes F, Russo RC, Pinho V, Teixeira MM, Sousa LP: Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol 2012; 92: 249-258
22. Liu X, Ma B, Malik AB, Tang H, Yang T, Sun B, Wang G, Minshall RD, Li Y, Zhao Y, Ye RD, Xu J: Bidirectional regulation of neutrophil migration by mitogenActivated protein kinases. Nat Immunol 2012; 13: 457-464
23. Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, Serhan CN: Lipoxin A 4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a Gprotein-linked lipoxin A 4 receptor. J Biol Chem 1997; 272: 6972-6978 (Pubitemid 27166397)
24. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM: IUnternational union of basic and clinical pharmacology. 73. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009; 61: 119-161
25. Chiang N, Serhan CN, Dahlen SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C: The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 2006; 58: 463-487 (Pubitemid 44394909)
26. Rajagopal S, Rajagopal K, Lefkowitz RJ: Teaching old receptors new tricks: Biasing seven-Transmembrane receptors. Nat Rev Drug Discov 2010; 9: 373-386
27. Krishnamoorthy S, Recchiuti A, Chiang N, Fredman G, Serhan CN: Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol 2012; 180: 2018-2027
28. Yamada T, Tani Y, Nakanishi H, Taguchi R, Arita M, Arai H: Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. FASEB J 2011; 25: 561-568
29. Isobe Y, Arita M, Matsueda S, Iwamoto R, Fujihara T, Nakanishi H, Taguchi R, Masuda K, Sasaki K, Urabe D, Inoue M, Arai H: IUdentification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid. J Biol Chem 2012; 287: 10525-10534
30. Schwab JM, Chiang N, Arita M, Serhan CN: Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007; 447: 869-874 (Pubitemid 46920139)
31. Stables MJ, Shah S, Camon EB, Lovering RC, Newson J, Bystrom J, Farrow S, Gilroy DW: Transcriptomic analyses of murine resolutionphase macrophages. Blood 2011; 118:e192-e208
32. Duffin R, Leitch AE, Fox S, Haslett C, Rossi AG: Targeting granulocyte apoptosis: Mechanisms, models, and therapies. Immunol Rev 2010; 236: 28-40
33. El Kebir D, Jozsef L, Khreiss T, Pan W, Petasis NA, Serhan CN, Filep JG: Aspirin-Triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: A novel mechanism for resolution of inflammation. J Immunol 2007; 179: 616-622 (Pubitemid 46986579)
34. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR: Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 2000; 164: 1663-1667 (Pubitemid 30108713)
35. Scannell M, Flanagan MB, deStefani A, Wynne KJ, Cagney G, Godson C, Maderna P: Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 2007; 178: 4595-4605 (Pubitemid 46492412)
36. Titos E, Rius B, Gonzalez-Periz A, Lopez-Vicario C, Moran-Salvador E, Martinez-Clemente M, Arroyo V, Claria J: Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol 2011; 187: 5408-5418
37. Csoka B, Selmeczy Z, Koscso B, Nemeth ZH, Pacher P, Murray PJ, Kepka-Lenhart D, Morris SM Jr, Gause WC, Leibovich SJ, Hasko G: Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J 2012; 26: 376-386
38. Schif-Zuck S, Gross N, Assi S, Rostoker R, Serhan CN, Ariel A: Saturated-efferocytosis generates pro-resolving CD11b low macrophages: Modulation by resolvins and glucocorticoids. Eur J Immunol 2011; 41: 366-379
39. Gomez IG, Tang J, Wilson CL, Yan W, Heinecke JW, Harlan JM, Raines EW: Metalloproteinase-mediated shedding of integrin beta2 promotes macrophage efflux from inflammatory sites. J Biol Chem 2012; 287: 4581-4589
40. Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ, Solito E, Serhan CN: Endogenous lipidAnd peptide-derived antiinflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A 4 receptor. Nat Med 2002; 8: 1296-1302 (Pubitemid 35373563)
41. Ernst S, Lange C, Wilbers A, Goebeler V, Gerke V, Rescher U: An annexin 1 N-Terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J Immunol 2004; 172: 7669-7676 (Pubitemid 38747633)
42. Hayhoe RP, Kamal AM, Solito E, Flower RJ, Cooper D, Perretti M: Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: IUndication of distinct receptor involvement. Blood 2006; 107: 2123-2130 (Pubitemid 43289398)
43. Gavins FN, Yona S, Kamal AM, Flower RJ, Perretti M: Leukocyte antiadhesive actions of annexin 1: ALXRAnd FPR-related anti-inflammatory mechanisms. Blood 2003; 101: 4140-4147 (Pubitemid 36857897)
44. Fiore S, Ryeom SW, Weller PF, Serhan CN: Lipoxin recognition sites. Specific binding of labeled lipoxin A 4 with human neutrophils. J Biol Chem 1992; 267: 16168-16176
45. Chiang N, Fierro IM, Gronert K, Serhan CN: Activation of lipoxin A(4) receptors by aspirin-Triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med 2000; 191: 1197-1208
46. Bena S, Brancaleone V, Wang JM, Perretti M, Flower RJ: Annexin A1 interaction with the FPR2/ALX receptor: IUdentification of distinct domains and downstream associated signaling. J Biol Chem 2012; 287: 24690-24697
47. Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, Gray M, D'Acquisto F, Buckingham JC, Perretti M, Flower RJ: Anti-inflammatory role of the murine formyl-peptide receptor 2: Ligand-specific effects on leukocyte responses and experimental inflammation. J Immunol 2010; 184: 2611-2619
48. Chen K, Le Y, Liu Y, Gong W, Ying G, Huang J, Yoshimura T, Tessarollo L, Wang JM: A critical role for the G protein-coupled receptor MFPR2 in airway inflammation and immune responses. J Immunol 2010; 184: 3331-3335
49. Chen K, Liu M, Liu Y, Yoshimura T, Shen W, Le Y, Durum S, Gong W, Wang C, Gao JL, Murphy PM, Wang JM: Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis. J Clin Invest 2013
50. Tae YM, Park HT, Moon HG, Kim YS, Jeon SG, Roh TY, Bae YS, Gho YS, Ryu SH, Kwon HS, Kim YK: Airway activation of formyl peptide receptors inhibits Th1 and Th17 cell responses via inhibition of mediator release from immune and inflammatory cells and maturation of dendritic cells. J Immunol 2012; 188: 1799-1808
51. Kim SD, Kim YK, Lee HY, Kim YS, Jeon SG, Baek SH, Song DK, Ryu SH, Bae YS: The agonists of formyl peptide receptors prevent development of severe sepsis after microbial infection. J Immunol 2010; 185: 4302-4310
52. Recchiuti A, Serhan CN: Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation. Front Immunol 2012; 3: 298
53. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN: Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci USA 2010; 107: 1660-1665
54. Norling LV, Dalli J, Flower RJ, Serhan CN, Perretti M: Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: Receptor-dependent actions. Arterioscler Thromb Vasc Biol 2012; 32: 1970-1978
55. Morris T, Stables M, Colville-Nash P, Newson J, Bellingan G, de Souza PM, Gilroy DW: Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc Natl Acad Sci USA 2010; 107: 8842-8847
56. Simiele F, Recchiuti A, Mattoscio D, De Luca A, Cianci E, Franchi S, Gatta V, Parolari A, Werba JP, Camera M, Favaloro B, Romano M: Transcriptional regulation of the human FPR2/ALX gene: Evidence of a heritable genetic variant that impairs promoter activity. FASEB J 2012; 26: 1323-1333
57. Patel HB, Montero-Melendez T, Greco KV, Perretti M: Melanocortin receptors as novel effectors of macrophage responses in inflammation. Front Immunol 2011; 2: 41
58. Patel HB, Bombardieri M, Sampaio AL, D'Acquisto F, Gray M, Grieco P, Getting SJ, Pitzalis C, Perretti M: Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis. FASEB J 2010; 24: 4835-4843
59. Patel HB, Kornerup KN, Sampaio AL, D'Acquisto F, Seed MP, Girol AP, Gray M, Pitzalis C, Oliani SM, Perretti M: The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis. Ann Rheum Dis 2012; 71: 1872-1880
60. Cardini S, Dalli J, Fineschi S, Perretti M, Lungarella G, Lucattelli M: Genetic ablation of the FPR1 gene confers protection from smokinginduced lung emphysema in mice. Am J Respir Cell Mol Biol 2012; 47: 332-339
61. Matheson M, Rynell AC, McClean M, Berend N: Cigarette smoking increases neutrophil formyl methionyl leucyl phenylalanine receptor numbers. Chest 2003; 123: 1642-1646 (Pubitemid 36549787)
62. Stockley RA, Grant RA, Llewellyn-Jones CG, Hill SL, Burnett D: Neutrophil formyl-peptide receptors. Relationship to peptide-induced responses and emphysema. Am J Respir Crit Care Med 1994; 149: 464-468 (Pubitemid 24068997)
63. Hashimoto A, Hayashi I, Murakami Y, Sato Y, Kitasato H, Matsushita R, Iizuka N, Urabe K, Itoman M, Hirohata S, Endo H: Antiinflammatory mediator lipoxin A 4 and its receptor in synovitis of patients with rheumatoid arthritis. J Rheumatol 2007; 34: 2144-2153 (Pubitemid 350076871)
64. Kim HJ, Cho SH, Park JS, Lee TH, Lee EJ, Kim YH, Uh ST, Chung IY, Kim MK, Choi IS, Park BL, Shin HD, Park CS: Association analysis of formyl peptide receptor 2 (FPR2) polymorphisms and aspirin exacerbated respiratory diseases. J Hum Genet 2012; 57: 247-253
65. Cooke GS, Campbell SJ, Bennett S, Lienhardt C, McAdam KP, Sirugo G, Sow O, Gustafson P, Mwangulu F, van Helden P, Fine P, Hoal EG, Hill AV: Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. Am J Respir Crit Care Med 2008; 178: 203-207 (Pubitemid 351957779)
66. Perretti M: Endogenous mediators that inhibit the leukocyte-endothelium interaction. Trends Pharmacol Sci 1997; 18: 418-425 (Pubitemid 27521059)
67. Parkinson JF: Lipoxin and synthetic lipoxin analogs: An overview of anti-inflammatory functions and new concepts in immunomodulation. Inflamm Allergy Drug Targets 2006; 5: 91-106 (Pubitemid 43796671)
68. Perretti M, Flower RJ: Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol 1993; 150: 992-999 (Pubitemid 23133679)
69. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K: Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000; 192: 1197-1204
70. Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN: Novel docosatrienes and 17s-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 2003; 278: 14677-14687 (Pubitemid 36799790)
71. Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, Oh SF, Spite M: Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 2009; 206: 15-23
72. Yang R, Fredman G, Krishnamoorthy S, Agrawal N, Irimia D, Piomelli D, Serhan CN: Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signals. J Biol Chem 2011; 286: 31532-31541
73. Nadkarni S, Cooper D, Brancaleone V, Bena S, Perretti M: Activation of the annexin A1 pathway underlies the protective effects exerted by estrogen in polymorphonuclear leukocytes. Arterioscler Thromb Vasc Biol 2011; 31: 2749-2759
74. Hasko G, Linden J, Cronstein B, Pacher P: Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008; 7: 759-770
75. El Kebir D, Gjorstrup P, Filep JG: Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc Natl Acad Sci USA 2012; 109: 14983-14988
76. Perretti M, Solito E: Annexin 1 and neutrophil apoptosis. Biochem Soc Trans 2004; 32: 507-510 (Pubitemid 38813550)
77. Weinberger B, Quizon C, Vetrano AM, Archer F, Laskin JD, Laskin DL: Mechanisms mediating reduced responsiveness of neonatal neutrophils to lipoxin A 4 . Pediatr Res 2008; 64: 393-398
78. Cash JL, Christian AR, Greaves DR: Chemerin peptides promote phagocytosis in a ChemR23And Syk-dependent manner. J Immunol 2010; 184: 5315-5324
79. Koroskenyi K, Duro E, Pallai A, Sarang Z, Kloor D, Ucker DS, Beceiro S, Castrillo A, Chawla A, Ledent CA, Fesus L, Szondy Z: IUnvolvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation. J Immunol 2011; 186: 7144-7155
80. Frasch SC, Berry KZ, Fernandez-Boyanapalli R, Jin HS, Leslie C, Henson PM, Murphy RC, Bratton DL: NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A. J Biol Chem 2008; 283: 33736-33749
81. Serhan CN, Dalli J, Karamnov S, Choi A, Park CK, Xu ZZ, Ji RR, Zhu M, Petasis NA: Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J 2012; 26: 1755-1765
82. Liu Y, Cousin JM, Hughes J, Van Damme J, Seckl JR, Haslett C, Dransfield I, Savill J, Rossi AG: Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol 1999; 162: 3639-3646 (Pubitemid 29313619)
83. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN: Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005; 201: 713-722 (Pubitemid 40395117)
84. Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, Hendrick AG, Carlton MB, Greaves DR: Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008; 205: 767-775 (Pubitemid 351549876)
85. Dalm VA, van Hagen PM, van Koetsveld PM, Achilefu S, Houtsmuller AB, Pols DH, van der Lely AJ, Lamberts SW, Hofland LJ: Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. Am J Physiol Endocrinol Metab 2003; 285:E344-E353 (Pubitemid 36899708)
86. Weinstock JV, Elliott D: The somatostatin immunoregulatory circuit present at sites of chronic inflammation. Eur J Endocrinol 2000; 143(suppl 1):S15-S19
87. Blasko E, Haskell CA, Leung S, Gualtieri G, Halks-Miller M, Mahmoudi M, Dennis MK, Prossnitz ER, Karpus WJ, Horuk R: Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J Neuroimmunol 2009; 214: 67-77
88. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM: The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 1996; 17: 675-679 (Pubitemid 26238403)
89. Getting SJ, Allcock GH, Flower R, Perretti M: Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J Leukoc Biol 2001; 69: 98-104 (Pubitemid 32095123)
90. Frasch SC, Fernandez-Boyanapalli RF, Berry KZ, Leslie CC, Bonventre JV, Murphy RC, Henson PM, Bratton DL: Signaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of RAC activity. J Biol Chem 2011; 286: 12108-12122
91. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM: GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142: 687-698